Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

551
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
551
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

566
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
566
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

745
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
745
Improving Translational Accuracy02:07

Improving Translational Accuracy

14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

STAG: Biologically guided spatial transcriptomics prediction via hypergraph learning.

Medical image analysis·2026
Same author

TV-3DG: Mastering Text-to-3D Customized Generation with Visual Prompt.

IEEE transactions on pattern analysis and machine intelligence·2025
Same author

Mode Hypergraph Neural Network.

IEEE transactions on neural networks and learning systems·2025
Same author

Generating Hypergraph-Based High-Order Representations of Whole-Slide Histopathological Images for Survival Prediction.

IEEE transactions on pattern analysis and machine intelligence·2022
Same author

Cost-Sensitive Uncertainty Hypergraph Learning for Identification of Lymph Node Involvement With CT Imaging.

Frontiers in medicine·2022
Same author

Big-Hypergraph Factorization Neural Network for Survival Prediction From Whole Slide Image.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2022

Related Experiment Video

Updated: Jan 14, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

M3Surv: Fusing Multi-slide and Multi-omics for Memory-augmented robust Survival prediction.

Mingcheng Qu1, Guang Yang1, Donglin Di2

  • 1Faculty of Computing, Harbin Institute of Technology, Harbin, China.

Medical Image Analysis
|October 22, 2025
PubMed
Summary
This summary is machine-generated.

M³Surv integrates multi-pathology slides (Fresh Frozen and Formalin-Fixed Paraffin-Embedded) with multi-omics data for improved cancer survival prediction. The framework robustly handles missing data, outperforming existing methods.

Keywords:
Multi-omicsMulti-slideMultimodalSurvival prediction

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 14, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Area of Science:

  • Computational biology
  • Biomedical informatics
  • Cancer research

Background:

  • Personalized oncology relies on multimodal survival prediction.
  • Current methods often use only FFPE slides and single omics, neglecting FF slides and multi-omics data.
  • Missing data due to clinical constraints limits conventional fusion models.

Purpose of the Study:

  • To develop a framework, M³Surv, for integrating multi-pathology slides (FF and FFPE) with multi-omics data.
  • To address the challenge of missing modalities in survival prediction models.
  • To enhance the accuracy and applicability of cancer survival prediction.

Main Methods:

  • Utilized a divide-and-conquer hypergraph learning for multi-slide fusion, capturing intra- and inter-slide relationships.
  • Integrated multi-omics data (proteomics, transcriptomics) with pathology features using interactive cross-attention.
  • Introduced a prototype-based memory bank to impute missing modalities during inference.

Main Results:

  • M³Surv achieved an average 2.2% improvement in C-Index across five TCGA cancer datasets and an in-house dataset.
  • Demonstrated superior performance compared to state-of-the-art survival prediction methods.
  • Showcased strong stability and robustness in scenarios with missing data modalities.

Conclusions:

  • M³Surv effectively integrates diverse data types for multimodal survival prediction.
  • The framework's ability to handle missing data enhances its clinical applicability.
  • M³Surv offers a promising approach for data-incomplete cancer survival prediction.